Find what you were looking for? Share your thoughts with a short survey

Biomedical Research Centres and NIHR funded facilities

Biomedical Research Centres (BRCs) are at the heart of our mission to translate scientific research into patient treatments.Research

King’s Health Partners is in the unique position of hosting two of the UK’s 20 National Institute for Health Research (NIHR) Biomedical Research Centres. 

NIHR BRCs support researchers and clinicians to translate lab-based discoveries into new cutting-edge treatments, technologies, diagnostics and other interventions for patients.

The substantial levels of sustained funding which BRCs receive create an environment in which scientific endeavour can thrive, attract the foremost talent and produce world-class outputs, hence contributing to the nation’s international competitiveness as a major component of our knowledge economy.

The aims of NIHR BRCs are to:

  • drive innovation in the prevention, diagnosis and treatment of ill-health
  • translate advances in biomedical research into benefits for patients
  • provide a key component of the NHS contribution to our nation’s international competitiveness by making the best Centres even better.

NIHR BRC at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London

The Centre comprises nine research themes: Cardiovascular disease, cutaneous medicine, genomic medicine. Infection and immunity, imaging science, transplantation, oral health, regenerative medicine and cellular therapy, and women and children’s health.BRC_graphic_floor_plan

The main aim of the centre is turning scientific discoveries into medical improvements and providing better healthcare through research.

Their expertise in developing advanced therapeutics and experimental medicines has enabled them to develop a wide portfolio of clinical trials investigating conditions such as diabetes, head and neck cancers, liver and renal disease, and developing therapies that can prevent organ rejection following transplantation. The LEAP study of peanut allergy in children has led to a change in the official national feeding guidelines.

They conduct pioneering world-first clinical trials across a wide range of research areas, while also developing state-of-the-art research infrastructure to better support our dedicated researchers and industry to discover new disease biomarkers and develop innovative treatments for patients.

Find out more about what they do, news updates and their events

Brain scan imagesNIHR Maudsley BRC at South London and Maudsley NHS Foundation Trust and King’s College London  

The NIHR Maudsley Biomedical Research Centre (BRC) brings together scientists, clinicians, allied health professionals, service users and carers from across South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience at King's College London. 

The centre delivers experimental medicine and early phase translational research in clinical disorders accounting for 13 of the top 25 contributors to ill health globally, including mental health, dementia and pain, as well as those with the biggest risks to population health, including: substance use, smoking, alcohol and obesity. Its aim is to accelerate the translation of the latest scientific discoveries into first-in-man clinical trials and other well-designed studies. The findings from these studies can then be developed and implemented to produce new tests and treatments for people with mental and neurological disorders.

Visit their news and events page to find out more about the work they do.

NIHR Clinical Research Facilities for Experimental Medicine

We host two NIHR Clinical Research Facilities for Experimental Medicine – one at Guy’s and St Thomas’ and one at South London and Maudsley. 

NIHR/Wellcome Trust King’s Clinical Research Facility

The King’s Clinical Research Facility is a pioneering collaboration involving the NHS, academia and industry to support world-leading research across physical and mental healthcare. 

Experimental Cancer Medicine Centre

King’s College London hosts one of the UK’s 18 Experimental Cancer Medicine Centres of scientific and clinical excellence. There is a national network of experimental cancer medicine centres, which has been funded by Cancer Research UK and the Department of Health. 

NIHR Cardiovascular Healthcare Technology Co-operative (HTC)

The NIHR Cardiovascular Healthcare Technology Co-operative (HTC) has been set up to identify, encourage and facilitate the development of new medical devices and technology driven solutions that will improve the diagnosis, treatment and well-being of patients with cardiovascular disease.

Research Design Services London

Research Design Services (RDS) are an NIHR-funded initiative which supports researchers to develop and design high-quality research proposals. Research Design Services London is a collaborative project for the London area. It is led by King’s College London, in partnership with Imperial College London, Queen Mary University of London and University College London.